Drug class
Interleukin-2 Receptor Blocking Antibody
Mechanism of action
Interleukin 2 Receptor Antagonists [MoA]
General use cases
- acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine, USP (MODIFIED), and corticosteroids
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
